Breaking News Instant updates and real-time market news.

SWKS

Skyworks

$65.18

0.71 (1.10%)

, AAPL

Apple

$150.77

2.95 (2.00%)

07:43
01/09/19
01/09
07:43
01/09/19
07:43

Skyworks price target lowered to $84 from $96 at Canaccord

Canaccord analyst T. Michael Walkley lowered his price target on Skyworks (SWKS) to $84 from $96 following its preannouncement indicating weak smartphone sales from its leading customers, Apple (AAPL) and Samsung (SSNLF), would lead to lower revenues. The analyst also lowered his estimates due to weak global trends including Android smartphones. He still believes, however, that the company's diverse portfolio positions its broad market division for double digit annual growth and Walkley maintained his Buy rating on Skyworks shares.

SWKS

Skyworks

$65.18

0.71 (1.10%)

AAPL

Apple

$150.77

2.95 (2.00%)

SSNLF

Samsung

$0.00

(0.00%)

  • 09

    Jan

  • 22

    Jan

  • 05

    Feb

SWKS Skyworks
$65.18

0.71 (1.10%)

01/09/19
RILY
01/09/19
NO CHANGE
Target $80
RILY
Neutral
Skyworks price target lowered to $80 from $89 at B. Riley FBR
B. Riley FBR analyst Craig Ellis lowered his price target for Skyworks Solutions saying feared mobility weakness drove the company's reduced Q1 outlook. He reiterates a Neutral rating on the shares.
01/07/19
01/07/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Skyworks (SWKS) downgraded to Perform from Outperform at Oppenheimer with analyst Rick Schafer citing the current "semiconductor correction" as well as "continued negative" smartphone news. 2. Snap (SNAP) downgraded to Hold from Buy at Pivotal Research with analyst Brian Wieser saying concerns around employee churn are playing out. 3. PNC Financial (PNC) downgraded to Neutral from Buy at Goldman Sachs with analyst Richard Ramsden saying commercial loan growth has fallen 7 percentage points and is likely to track industry growth rates more closely from here. 4. Quarterhill (QTRH) downgraded to Hold from Buy at Canaccord. 5. Urban Outfitters (URBN) downgraded to Neutral from Overweight at JPMorgan with analyst Matthew Boss saying he sees a "flattish comp downside scenario neutralizing the risk/reward profile." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/07/19
DADA
01/07/19
NO CHANGE
Target $85
DADA
Buy
Skyworks price target lowered to $85 from $115 at DA Davidson
DA Davidson analyst Thomas Diffely lowered his price target on Skyworks to $85, also lowering his FY19 EPS view on the stock to $7.15 from $7.45. The analyst cites the "combination of ongoing trade war chatter with China and growing concerns over a potential slowdown in the US economy", leading to reduced demand for advanced handsets and weighing on the company's mobility business. While Diffely sees 2019 as a "transition year" for Skyworks, he keeps a Buy rating on the shares ahead of the 5G transition catalyst in 2020, saying that the company should be a "key beneficiary of complexity growth in the years ahead."
01/07/19
OPCO
01/07/19
DOWNGRADE
OPCO
Perform
Skyworks downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Rick Schafer downgraded Skyworks Solutions (SWKS) to Perform and removed his prior $110 price target. The stock closed Friday up $2.91 to $63.63. The analyst reduced his estimates for the company and group to reflect the current "semiconductor correction" as well as "continued negative" smartphone news. Particular concern is Apple's (AAPL) recent 8% sales miss, blamed on the iPhone and China, Schafer tells investors in a research note. Apple is Skyworks' largest customer at ~40% of sales, adds the analyst. Schafer sees a balanced risk/reward for Skyworks shares amid a "challenged growth environment" for the company and handset component peers.
AAPL Apple
$150.77

2.95 (2.00%)

01/07/19
UBSW
01/07/19
NO CHANGE
Target $180
UBSW
Buy
Apple miss a combination of share loss and general market weakness, says UBS
UBS analyst Timothy Arcuri analyzed the Apple miss announced last week in an attempt to determine whether the miss was due to the company losing market share or general handset market weakness in China. His analysis suggests it is a combination of both, concluding iPhone demand appears to have fallen precipitously but also the China market is clearly soft. The analyst believes a trade deal could help, but China issues could linger. Arcuri maintained his Buy rating and $180 price target on Apple shares.
01/08/19
BTIG
01/08/19
NO CHANGE
BTIG
Pixel 3 may be first smartphone with CBRS spectrum, says BTIG
Google's (GOOG, GOOGL) Pixel 3 could be the first smartphone enabled with Citizens Broadband Radio Service spectrum, BTIG analyst Walter Piecyk tells investors in a research note. Pixel 3 launched exclusively with Verizon (VZ) three months ago and at launch, it included Band 42, which includes a portion of the spectrum used for CBRS, says the analyst. Further, he points out that Google requested that the Federal Communications Commission allow it to activate CBRS/Band 48 in the Pixel 3 through a software upgrade. It is unclear if Apple (AAPL) could upgrade its iPhones to CBRS with a software upgrade, like Google, Piecyk contends.
01/08/19
WELS
01/08/19
NO CHANGE
Target $160
WELS
Market Perform
Concerns over sustainability of Apple Services growth increasing, says Wells Fargo
Wells Fargo analyst Aaron Rakers says that although Apple has continued to deliver impressive Services growth, his discussions with investors have highlighted increased concerns/questions over the sustainability of these trends going forward. The analyst thinks unpacking Apple's key services growth drivers will be increasingly important as investors gauge growth sustainability. He reiterates a Market Perform rating and $160 price target on the shares.
SSNLF Samsung
$0.00

(0.00%)

12/10/18
BNCH
12/10/18
NO CHANGE
Target $35
BNCH
Buy
Xperi settlement removes Samsung uncertainty, says Benchmark
After Xperi (XPER) announced a patent license agreement with Samsung (SSNLF) that it said settles all outstanding legal matters between the parties, Benchmark analyst Gary Mobley said he believes the pact "removes nearly all of the uncertainty that has plagued the shares during the past two years." He raised his price target on Xperi shares to $35 from $25 to account for his higher FY19 estimates and keeps an Buy rating on the stock, which he still views as undervalued.
12/11/18
CHLM
12/11/18
NO CHANGE
Target $28
CHLM
Buy
Xperi price target raised to $28 from $20 at Craig-Hallum
Craig-Hallum analyst Richard Shannon raised his price target for Xperi to $28 from $20 (XPER), while reiterating a Buy rating on the shares. The analyst notes that the the company's Samsung (SSNLF) settlement is a critical event in its history as it shows that its portfolio has substantial ongoing value, and that Xperi is willing to be patient to find a fair settlement.
01/08/19
NEED
01/08/19
NO CHANGE
NEED
Hold
Needham stays Hold on Micron, says Samsung confirmed weakening outlook
Needham analyst Rajvindra Gill keeps a Hold rating on Micron Technology (MU) after Samsung (SSNLF) lowered its preliminary outlook for Q4. Similar to Micron, Samsung cited excess inventory at its hyperscaler customers and weaker than expected demand in smartphones, Gill tells investors in a research note. Samsung also reiterated a similar view of Micron's that it expects a second half of 2019 rebound driven by new central processing unit architectures and launches of new smartphones, adds the analyst. Gill, however, believes visibility into the second half of 2019 remains limited. Based on industry conversations, he thinks excess inventory at hypersacalers will persist for at least another 3-6 months. Further, the slowing Chinese economy makes him cautious on overall demand conditions in the first half of the year. As such, Gill says that while Micron is trading at historical low valuation multiples, the stock has further downside if demand conditions worsen. Shares of Micron are down 3%, or $1.11, to $32.89 in morning trading.
11/26/18
RBCM
11/26/18
NO CHANGE
Target $29
RBCM
Outperform
HP executing well, positioned to report in-line Q4, says RBC Capital
RBC Capital analyst Amit Daryanani kept his Outperform rating and $29 price target on HP Inc (HPQ) ahead of its earnings this week, saying the company is positioned to report inline result for Q4 as it continues to execute well. The analyst notes that the stock offers a 10% free cash flow yield and could see some multiple expansion from better organic earnings growth, even though the company is contending with FX related headwinds, lower memory pricing trends, and the declining pace of install base at Samsung (SSNLF) in printing.

TODAY'S FREE FLY STORIES

GBT

Global Blood Therapeutics

$50.04

-0.45 (-0.89%)

07:19
02/22/19
02/22
07:19
02/22/19
07:19
Initiation
Global Blood Therapeutics initiated  »

Global Blood Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

FIT

Fitbit

$6.62

-0.03 (-0.45%)

07:18
02/22/19
02/22
07:18
02/22/19
07:18
Downgrade
Fitbit rating change  »

Fitbit downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 27

    Feb

STMP

Stamps.com

, FDX

FedEx

$182.28

0.52 (0.29%)

07:18
02/22/19
02/22
07:18
02/22/19
07:18
Recommendations
Stamps.com, FedEx, UPS, Amazon.com analyst commentary  »

Stamps.com should return…

STMP

Stamps.com

FDX

FedEx

$182.28

0.52 (0.29%)

UPS

UPS

$111.76

0.68 (0.61%)

AMZN

Amazon.com

$1,619.84

-2.26 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 18

    Mar

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

ARGX

Argenx

$122.20

-2.84 (-2.27%)

07:18
02/22/19
02/22
07:18
02/22/19
07:18
Initiation
Argenx initiated  »

Argenx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$418.66

-3.9 (-0.92%)

07:17
02/22/19
02/22
07:17
02/22/19
07:17
Initiation
Regeneron initiated  »

Regeneron assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 11

    Mar

  • 11

    Mar

  • 28

    Apr

  • 13

    May

BIIB

Biogen

$320.99

-14.02 (-4.18%)

07:15
02/22/19
02/22
07:15
02/22/19
07:15
Initiation
Biogen initiated  »

Biogen assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    May

MGLN

Magellan Health

$70.81

-1.6 (-2.21%)

07:15
02/22/19
02/22
07:15
02/22/19
07:15
Hot Stocks
Starboard to nominate full slate for election to Magellan Health board »

Starboard Value, one of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

MO

Altria Group

$50.38

-0.14 (-0.28%)

07:14
02/22/19
02/22
07:14
02/22/19
07:14
Periodicals
Despite flavored vape ban, Juul sees $3.4B in revenue in 2019, Bloomberg says »

Despite the fact that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALXN

Alexion

$127.56

-2.17 (-1.67%)

07:12
02/22/19
02/22
07:12
02/22/19
07:12
Initiation
Alexion initiated  »

Alexion initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

MCRB

Seres Therapeutics

$5.83

-0.07 (-1.19%)

07:11
02/22/19
02/22
07:11
02/22/19
07:11
Initiation
Seres Therapeutics initiated  »

Seres Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 18

    May

TREE

LendingTree

$310.22

-4.78 (-1.52%)

07:11
02/22/19
02/22
07:11
02/22/19
07:11
Recommendations
LendingTree analyst commentary  »

LendingTree price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 14

    Mar

  • 19

    Mar

ANAB

AnaptysBio

$64.87

-0.12 (-0.18%)

07:11
02/22/19
02/22
07:11
02/22/19
07:11
Initiation
AnaptysBio initiated  »

AnaptysBio initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$88.80

0.35 (0.40%)

07:10
02/22/19
02/22
07:10
02/22/19
07:10
Hot Stocks
United Airlines names Robert Rivkin as SVP and General Counsel »

United Airlines named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

RUTH

Ruth's Hospitality

$25.01

0.35 (1.42%)

07:09
02/22/19
02/22
07:09
02/22/19
07:09
Hot Stocks
Ruth's Hospitality raises quarterly dividend to 13c per share »

Subsequent to the end of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

MYGN

Myriad Genetics

$31.73

-0.19 (-0.60%)

07:09
02/22/19
02/22
07:09
02/22/19
07:09
Hot Stocks
Myriad Genetics announces Vectra study data published »

Myriad Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 11

    Mar

INTU

Intuit

$234.85

-1.06 (-0.45%)

07:09
02/22/19
02/22
07:09
02/22/19
07:09
Recommendations
Intuit analyst commentary  »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

FAMI

Farmmi

$3.07

-0.04 (-1.29%)

07:09
02/22/19
02/22
07:09
02/22/19
07:09
Hot Stocks
Farmmi, Fenghengda Food enter cooperation agreement »

Farmmi announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYL

Tyler Technologies

$208.83

-4.36 (-2.05%)

07:09
02/22/19
02/22
07:09
02/22/19
07:09
Downgrade
Tyler Technologies rating change  »

Tyler Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

TROX

Tronox

$11.35

(0.00%)

07:08
02/22/19
02/22
07:08
02/22/19
07:08
Recommendations
Tronox analyst commentary  »

Tronox shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

LX

LexinFintech

$10.32

0.03 (0.29%)

07:08
02/22/19
02/22
07:08
02/22/19
07:08
Hot Stocks
LexinFintech names Shirley Yang as Chief Human Resources Officer »

LexinFintech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$117.14

-0.87 (-0.74%)

07:08
02/22/19
02/22
07:08
02/22/19
07:08
Hot Stocks
Wayfair reports 15.2M active customers, up 37.9% year-over-year »

The number of active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 03

    Mar

CRM

Salesforce

$159.66

1.12 (0.71%)

07:08
02/22/19
02/22
07:08
02/22/19
07:08
Recommendations
Salesforce analyst commentary  »

Oppenheimer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 03

    Mar

  • 04

    Mar

RUTH

Ruth's Hospitality

$25.01

0.35 (1.42%)

07:07
02/22/19
02/22
07:07
02/22/19
07:07
Earnings
Ruth's Hospitality reports Q4 EPS ex-items 50c, consensus 49c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

SRE

Sempra Energy

$117.67

0.5 (0.43%)

07:06
02/22/19
02/22
07:06
02/22/19
07:06
Hot Stocks
Sempra Energy raises annual dividend 8.1% to $3.87 per share »

Sempra Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

W

Wayfair

$117.14

-0.87 (-0.74%)

07:05
02/22/19
02/22
07:05
02/22/19
07:05
Earnings
Wayfair reports Q4 adjusted EPS ($1.12), consensus (1.28) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.